Andrea Marzocco
Azienda Ospedaliero-Universitaria Careggi, University of Florence
Papers
3
Total Citations
17
H-Index
2
About
Dr. Andrea Marzocco is a urologic surgeon and researcher whose work centers on refining risk stratification and surgical decision-making in prostate and renal cancers. His major contributions lie in challenging conventional treatment timelines and pathological classifications. In a pivotal 2022 study (10 citations), he demonstrated that upstaged pT3a renal tumors with fat invasion after robot-assisted partial nephrectomy exhibit distinct prognostic features, proposing a new subclassification to better guide postoperative management. Dr. Marzocco further addressed a critical clinical dilemma in a 2024 study (6 citations), showing that deferring prostate cancer surgery does not significantly increase the risk of pathological upstaging, thereby supporting the safety of delayed treatment in appropriately selected patients. Most recently, he developed and internally validated a novel predictive model (2025) for individualized risk assessment in prostate cancer, aiming to personalize treatment strategies. Through these works, Dr. Marzocco is advancing precision oncology, offering urologists evidence-based tools to balance oncologic control with quality of life. His research, though early in citation accrual, is shaping contemporary urologic practice by challenging dogma and promoting tailored, patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3